Linda Scully

The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

E. Jenny Heathcote, Karen Cauch‐Dudek, Valery Walker et al. · Hepatology · 1994 · 442 citations

Hepatology, Biliary Tract, Biliary Cancer +15

Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis

Michael Wilschanski, Peter Chait, Judy Wade et al. · Hepatology · 1995 · 220 citations

Clinical Presentation, Gastroenterology, Pathology +18

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant α-interferon

J.A. McDonald, L. Caruso, Peter Karayiannis et al. · Hepatology · 1987 · 140 citations

Anti-ribosomal P Antibodies in Systemic Lupus Erythematosus: A Case-Control Study Correlating Hepatic and Renal Disease

Mark Hulsey, Rose Goldstein, Linda Scully et al. · Clinical Immunology and Immunopathology · 1995 · 114 citations

Translational Medicine, Renal Disease, Autoimmune Disease +13

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

M.R. Kilmurry, E. Jenny Heathcote, Karen Cauch‐Dudek et al. · Hepatology · 1996 · 93 citations · Full text

Mayo Model, Urology, Hepatology +14